Psoriatic lesional skin inhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2)

Journal of Pathology

Volumn 199, Issue 1, 2003, Pages 107-114

  van der Fits, Leslie ^a   van der Wel, Leontine I ^a   Laman, Jon D ^a   Prens, Errol P ^a   Verschuren, Martie C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Gene expression; Inflammatory skin disease; Interferon gamma; Transcription factor

Indexed keywords

CELL EXTRACT; GAMMA INTERFERON; INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; MESSENGER RNA;

ADULT; AGED; ARTICLE; BASAL CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; KERATINOCYTE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSORIASIS; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EPIDERMIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; INTERFERON TYPE II; MALE; MIDDLE AGED; PHOSPHOPROTEINS; PSORIASIS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; TRANSCRIPTION FACTORS;

EID: 0037223499     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1263     Document Type: Article

References (27)

1. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993; 101: 701-705.
2. Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999; 113: 752-759.
3. Chen SH, Arany I, Apisarnthanarax N, et al. Response of keratinocytes from normal and psoriatic epidermis to interferon-gamma differs in the expression of zinc-alpha(2)-glycoprotein and cathepsin D. FASEB J 2000; 14: 565-571.
4. Fransson J, Shen Q, Scheynius A, Hammar H. The effect of IFN-gamma on healthy and psoriatic keratinocytes in a skin equivalent model is influenced by the source of the keratinocytes and by their interactions with fibroblasts. Arch Dermatol Res 1996; 289: 14-20.
5. Fierlbeck G, Rassner G, Muller C. Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations. Arch Dermatol 1990; 126: 351-355.
6. Baker BS, Powles AV, Valdimarsson H, Fry L. An altered response by psoriatic keratinocytes to gamma interferon. Scand J Immunol 1988; 28: 735-740.
7. Nickoloff BJ, Mitra RS, Elder JT, Fisher GJ, Voorhees JJ. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions. Br J Dermatol 1989; 121: 161-174.
8. Grossman RM, Krueger J, Yourish D, et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci U S A 1989; 86: 6367-6371.
9. Faggioli L, Merola M, Hiscott J, et al. Molecular mechanisms regulating induction of interleukin-6 gene transcription by interferon-gamma. Eur J Immunol 1997; 27: 3022-3030.
10. Groves RW, Ross EL, Barker JN, MacDonald DM. Vascular cell adhesion molecule-1: expression in normal and diseased skin and regulation in vivo by interferon gamma. J Am Acad Dermatol 1993; 29: 67-72.
11. Sirsjo A, Karlsson M. Gidlof A, Rollman O, Torma H. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol 1996; 134: 643-648.
12. Xie Q, Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukoc Biol 1994; 56: 576-582.
13. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. Irf family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19: 623-655.
14. Taki S, Sato T, Ogasawara K, et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 1997; 6: 673-679.
15. Clavell M, Correa-Gracian H, Liu Z, et al. Detection of interferon regulatory factor-1 in lamina propria mononuclear cells in Crohn' s disease. J Pediatr Gastroenterol Nutr 2000; 30: 43-47.
16. Jackson M, Howie SEM, Weller RJ, Sabin E, Hunter JAA, McKenzie RC. Psoriatic keratinocytes show reduced stat-1α and IRF activation in response to IFN-γ. FASEB J 1999; 13: 495-502.
17. Hida S, Ogasawara K, Sato K, et al. CD8+ T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-α/β signaling. Immunity 2000; 13: 643-655.
18. Prens EP, Benne K, van Joost T, Benner R. The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells. J Invest Dermatol 1991; 96: 880-887.
19. Paliard X, de Waal Malefijt R, Yssel H, et al. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. J Immunol 1988; 141: 849-855.
20. Verschuren MC, van Bergen CJ, van Gastel-Mol EJ, Bogers AJ, van Dongen JJ. A DNA binding protein in human thymocytes recognizes the T cell receptor-delta-deleting element psi J alpha. J Immunol 1996; 156: 3806-3814.
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
22. Meijer D, Graus A, Kraay R, Langeveld A, Mulder MP, Grosveld G. The octamer binding factor Oct6: cDNA cloning and expression in early embryonic cells. Nucleic Acids Res 1990; 18: 7357-7365.
23. Pellegrini G, De Luca M, Orecchia G, et al. Expression, topography, and function of integrin receptors are severely altered in keratinocytes from involved and uninvolved psoriatic skin. J Clin Invest 1992; 89: 1783-1795.
24. Galvin S, Loomis C, Manabe M, Dhouailly D, Sun TT. The major pathways of keratinocyte differentiation as defined by keratin expression: an overview. Adv Dermatol 1989; 4: 277-299.
25. Mommers JM, van Rossum MM, van Erp PE, van De Kerkhof PC. Changes in keratin 6 and keratin 10 (co-) expression in lesional and symptomless skin of spreading psoriasis. Dermatology 2000; 201: 15-20.
26. Harada H, Takahashi E, Itoh S, Harada K, Hori TA, Taniguchi T. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol Cell Biol 1994; 14: 1500-1509.
27. Matthews D, Fry L, Powles A, et al. Evidence that a locus for familial psoriasis maps to chromosome 4q. Nature Genet 1996; 14: 231-233.